RUSSELL FRANK CO/ - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 139 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$40,000
-97.7%
4,694
-96.6%
0.00%
-100.0%
Q2 2015$1,710,000
-4.0%
138,297
-7.8%
0.00%0.0%
Q1 2015$1,782,000
-29.6%
150,049
-34.2%
0.00%
-25.0%
Q4 2014$2,530,000
+46.6%
228,103
+16.0%
0.00%
+33.3%
Q3 2014$1,726,000
+150.9%
196,622
+69.0%
0.00%
+200.0%
Q2 2014$688,000
+34300.0%
116,322
+23883.9%
0.00%
Q3 2013$2,000
+100.0%
485
+385.0%
0.00%
Q2 2013$1,0001000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,244,080$12,096,0004.51%
ALTFEST L J & CO INC 39,491$1,653,0001.15%
GARRISON BRADFORD & ASSOCIATES INC 82,700$446,0000.44%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,074,557$48,912,0000.40%
Virtus ETF Advisers LLC 87,477$472,0000.35%
Cannell & Co. 1,614,678$8,703,0000.32%
Birchview Capital, LP 44,000$237,0000.17%
STONERIDGE INVESTMENT PARTNERS LLC 180,534$973,0000.14%
HighPoint Advisor Group LLC 8,484$344,0000.12%
MARINER INVESTMENT GROUP LLC 63,090$340,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders